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The intracellular survival of Plasmodium falciparum
within human erythrocytes is dependent on export of
parasite proteins that remodel the host cell. Most ex-
ported proteins require a conserved motif (RxLxE/Q/D),
termed the Plasmodium export element (PEXEL) or vacu-
olar targeting sequence (VTS), for targeting beyond the
parasitophorous vacuole membrane and into the host
cell; however, the precise role of this motif in export is
poorly defined. We used transgenic P. falciparum ex-
pressing chimeric proteins to investigate the function of
thePEXELmotifforexport.ThePEXELconstitutesabifunc-
tional export motif comprising a protease recognition
sequence that is cleaved, in the endoplasmic reticulum,
fromproteinsdestined for export, in a PEXEL arginine- and
leucine-dependent manner. Following processing, the re-
maining conserved PEXEL residue is required to direct the
mature protein to the host cell. Furthermore, we demon-
strate that N acetylation of proteins following N-terminal
processing is a PEXEL-independent process that is insuf-
ficient for correct export to the host cell. This work defines
the role of each residue in the PEXEL for export into the
P. falciparum-infected erythrocyte.
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Four species of Plasmodium cause malaria in humans;
however, Plasmodium falciparum is responsible for the
most severe. Approximately 600 million people are in-
fected each year resulting in more than 2 million deaths (1).
Central to the intracellular survival of P. falciparum and
pathogenesis of malaria is the extensive remodelling of the
host erythrocyte during the parasite asexual blood stage
(reviewed in 2). Remodelling occurs in the absence of an
established secretory network in the host cell and enables
nutrient uptake and surface exposure of the major adhesin,
P. falciparum erythrocyte membrane protein 1 (PfEMP1)
(3–5), which mediates cytoadherence to microvascular
endothelia and placental trophoblasts, and facilitates
immune evasion by antigenic variation (reviewed in 6).
To remodel the infected erythrocyte, P. falciparum exports
effector proteins from within the parasite, through the
endoplasmic reticulum (ER), to the parasite membrane
and across the parasitophorous vacuole and parasitopho-
rous vacuole membrane into the host cell (7,8). In the case
of PfEMP1, the protein is trafficked with Maurer’s clefts,
which bud from the parasitophorous vacuole membrane, to
electrondenseknobsunderlyingthe erythrocytemembrane
into which it is inserted (9–11). In addition, P. falciparum
exports a variety of proteins that play a role in protein
trafficking (12–15), nutrient acquisition (16), knob formation
(17) and altered erythrocyte mechanical properties (14,18).
A conserved export motif termed Plasmodium export
element (PEXEL) (19) or vacuolar translocation signal
(VTS) (20) is required for export beyond the parasitopho-
rous vacuole membrane, either to the erythrocyte cytosol
(19,20) or to the hepatocyte cytosol in the parasite liver
stages (21). The PEXEL consists of a pentameric sequence
RxLxE/Q/D and is conserved across Plasmodia and pres-
ent in more than 300 P. falciparum proteins (22). This
includes proteins such as the knob-associated histidine-
rich protein (KAHRP), which is required for knob formation
(17) and glycophorin-binding protein 130 (GBP130) (23).
Recently, the PEXEL motif was shown to be a protease
cleavage site, with processing at the conserved leucine
and acetylation of the new N-terminus (24).
A definitive determination of the role of each conserved
PEXEL residue has not been reported, nor has the function
of N acetylation in export been characterised. In this work,
we use transgenic P. falciparum lines expressing mutant
chimaeras to elucidate the function of the PEXEL in protein
sorting and to characterise the potential relationship bet-
ween the PEXEL, N acetylation and export. This addresses
the early molecular events required for protein export to
the P. falciparum-infected erythrocyte.
Results
KAHRP and GBP130 are differentially processed at
the N-terminus before export in a PEXEL-dependent
manner
The PEXEL motif consists of RxLxE/Q/D and is required
for protein export beyond the parasitophorous vacuole
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www.traffic.dk 285membrane (19,20). This motif is proteolytically processed
during transit to the host cell (24). For consistency, the
transgenic P. falciparum lines described previously (19)
were used in the current study to analyse the N-termini of
different PEXEL chimaeras during export in infected eryth-
rocytes. The transgenic lines expressed the N-terminus of
KAHRP or GBP130, with a native or mutated PEXEL, fused
to green fluorescent protein (GFP) or yellow fluorescent
protein (YFP) at the C-terminus (Figure 1), as previously de-
scribed (19). The transgenic parasites express KAHRPR>A,
KAHRPL>A and KAHRPRLQ>A as GFP chimaeras as well as
KAHRPWT, GBP130WT, GBP130R>A, GBP130L>A, GBP130E>A
and GBP130RILE>A as YFP chimaeras, which were gener-
ated by transfection of plasmids (19). Transgenic parasites
expressing a KAHRPQ>A GFP chimaera were generated
using the vector pJABKQ>AGlux.1 (see Materials and
Methods).
To separate exported chimaeras (erythrocyte cytosol) from
nonexported chimaeras (parasite and parasitophorous vac-
uole) and enable visualisation of potential processing
differences, we used the selective pore-forming toxin
tetanolysin (25) followed by analysis of the fractions by
immunoblot with a-GFP antibodies. A number of different
sized GFP chimaerae was observed in the tetanolysin
pellets, suggesting PEXEL-dependent N-terminal process-
ing (Figure 2A,C). No size difference was observed for
chimaeras with a wild-type PEXEL between tetanolysin
supernatants (exported) and pellets (not exported)
(Figure 2B,D), suggesting PEXEL-dependent processing
occurred before translocation to the host cell. This agrees
with previous work that suggested PEXEL processing
occurred in the parasite ER before export (24).
PEXEL processing differed between wild type and mutant
KAHRP and GBP130 chimaerae. For KAHRP, with a wild-
type PEXEL, the protein was processed to smaller species
and efficiently exported (Figure 2B,G). However, for the
R>A, L>A and RLQ>A PEXEL mutants, we observed two
protein species (indicated by r and j, Figure 2A) that
were larger than observed for wild type and the Q>A
PEXEL mutant, suggesting that the specific amino acid
changes had interfered with normal processing and,
consequently, export (Figure 2A). The uppermost species
(r) was approximately 35 kDa, consistent with the pre-
dicted size of the full-length KAHRP chimaera (i.e. atypical
signal sequence still attached). The second species (j)
was approximately 31 kDa, consistent with processing of
the atypical signal sequence at/near the site predicted by
SignalP (
32LKC-SN
36). The 31-kDa species was clearly
larger than the bands observed for wild type and Q>A
PEXEL mutant proteins (Figure 2A,E), indicating that the
latter chimaeras were furtherprocessed atthe N-terminus.
Therefore, the R>A and L>A mutation in the KAHRP
PEXEL results in incorrect processing and, as a result,
the chimaeras are not exported to the erythrocyte in
measurable quantities (Figure 2B,G).
For GBP130, a protein species of approximately 33 kDa
was detected (indicated by j in Figure 2C) for the R>A,
L>A and RILE>A PEXEL mutants that was larger than the
wild type (indicated by H, Figure 2C) and E>A PEXEL
mutant (Figure 2C,F). The 33-kDa protein was a size
consistent with processing of the atypical signal sequence
at/near the site predicted by SignalP (
67ICG-DK
71) (Figure
2F). Full-length GBP130 chimaeras with the atypical sig-
nal sequence (predicted mass 39.7 kDa) were not obvi-
ously present in contrast to the KAHRP proteins (results
not shown). Furthermore, approximately 60% of the
GBP130L>A chimaera was processed to the same size as
the GBP130WT and GBP130E>A chimaeras (Figure 2C,
lanes 1, 3 and 4), suggesting that this mutation did not
ablate PEXEL cleavage, consistent with a proportion of the
cleaved protein being found in the tetanolysin supernatant
(Figure 2D). The E>A mutation did not affect processing of
the GBP130 PEXEL and some export of the protein did
occur; however, this was much less than the nonmutated
form. These results show that the conserved R and L
Figure 1: Structure of the chimaeric proteins. The first 69 residues of KAHRP or 99 residues of GBP130, containing a native or mutated
PEXEL, were fusedto GFP or YFP. All GBP130 chimaerasand theKAHRPWT chimaerawere expressed from the HSP86 promoter (19). The
remaining KAHRP chimaeras were expressed from the PfCRT promoter as in-frame fusions with GFPmut2.
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age. However, the E/Q>A mutation does not affect
processing but alters the level of export to the host cell.
It is noteworthy that we observed differences in episomal
expression of the different constructs, as reflected by the
quantity of aldolase in Figure 2A–D. It is possible that this
influenced the efficiency of N-terminal processing and
export to the host cell of the chimaeras.
Exported GBP130 is processed at the PEXEL
leucine and acetylated at the new N-terminus
To confirm the identityof the different processed chimaerae,
we used affinity purification and nano-liquid chromatography
Figure 2: Role of the PEXEL residues in processing and export to the erythrocyte. Immunoblots with a-GFP antibodies against
KAHRP chimaeras from tetanolysin pellets (A) and supernatant (B) or GBP130 chimaeras from tetanolysin pellets (C) and supernatant (D)
are shown. Antibodies to aldolase (48) were used as a permeabilisation control, as described previously (49) and reflects the quantity of
protein loaded in each lane. While equal proportions of pellet and supernatant were loaded for each chimaera, equal loadings could not be
achieved between different chimaeras because of differences in episomal expression. The densitometric analyses below (see G and H)
were thus limited to comparing only between pellet and supernatant fractions of the same chimaera. Upper bands in (D, lanes 2 and 3)
represent slight vacuolarleakage.E) Predictedproteinsizes ofKAHRP chimaeras afterdifferentialN-terminalprocessing;rrepresents full-
length chimaeras with signal sequence; j represents processing at/near the site predicted by SignalP; H represents chimaeras processed
downstream of prediction by SignalP (i.e. within the PEXEL); m represents degradation to GFP/YFP only (confirmed by MS; Figure S2). The
linker upstream of YFP in KAHRPWT (Figure 1) is not depicted here. While the N-termini of each KAHRP chimaera are the same, except for
the mutations shown, the C-terminal YFP linker in KAHRPWT explains the minor size shift in (A) and (B) between WT and other chimaeras
processed at the PEXEL (i.e. those depicted with w). F) Predicted protein sizes of GBP130 chimaeras after differential N-terminal processing.
Varyingexposureswithinthelinearrangeoftheblotsrepresentedin(A–D)werescannedathighresolutionanddensitometrywasundertaken
to approximately quantify the differential N-terminal processing and cellular localisation of KAHRP (G) and GBP130 (H) chimaeras. For each
chimaera, percentages were calculated by dividing the intensity of each band in the supernatant (exported to host) or pellet (ER or
parasitophorous vacuole) by the sum of the band intensities for that chimaera (total tagged chimaera) and multiplying by 100. Percentages
between chimaerae are directly comparable. WT, wild type; SS, signal sequence; PV, parasitophorous vacuole.
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the N-termini of the processed species. Transgenic
P. falciparum lines expressing KAHRPWT and GBP130WT
chimaeras were prepared and purified from the superna-
tant (exported protein) by immunoaffinity chromatography
with a-GFP agarose, separated by SDS–PAGE, verified by
immunoblot (Figure 3A,C) and excised from gels (Figure
3B,D). Purified chimaeras were reduced, alkylated and in-
gel digested with trypsin (GBP130) or chymotrypsin
(KAHRP) and subjected to LC-MS/MS to determine the
mass and amino acid sequence of N-terminal peptides.
The GBP130WT YFP chimaera was identified with 35%
sequence coverage and the most N-terminal peptide had
a mass of m/z 1178.49 and the sequence Ac-
87AEGEDT-
CARK
96 (Figure 3E). The nonacetylated form of this spe-
cies was not detected, illustrating the homogeneous
nature of the chimaera fraction. The identification of this
peptide indicates that proteolytic processing of the
GBP130 PEXEL occurred in vivo, with the PEXEL leucine
at the P1 position (i.e.
84RIL-AE
88), and the protein acety-
lated at the new N-terminus after processing, in agree-
ment with a previous study on other proteins (24). We
attempted to identify the PEXEL-containing chymotryptic
peptide with sequence  Ac-
57AQKQHEHHHHHHH
KGGRADPAF
78 from the KAHRPWT YFP chimaera; how-
ever, the configuration of the MALDI-Qstar quadrupole
time-of-flight instrument did not allow us to detect this
histidine-rich peptide. While we detected peptides on
the C-terminal side of the histidine-rich sequence (e.g.
113SVSGEGEGDATYGKL
127; results not shown), we were
unable to detect peptides on the N-terminal side of the
PEXEL despite the absence of histidines in that region,
consistent with in vivo cleavage of the chimaera within the
PEXEL. GBP130WT was processed at the PEXEL leucine
and immunoblots indicate that this occurs in a manner
dependent on arginine at the P3 position and leucine at the
P1 position. While we do not have definitive proteomic
data on the KAHRPWT cleavage, the immunodata and the
peptide sequence recovered are consistent with cleavage
at the leucine position of the PEXEL.
PEXEL processing and N acetylation occur in
endogenous P. falciparum proteins
Analysis of the total proteomic data obtained in this study
revealed a number of endogenous P. falciparum proteins
Figure 3: Affinity purification of ex-
ported GBP130WT and KAHRPWT chi-
maeras and MS. Immunoblot (A) and
coomassie gel (B) of the GBP130WT
chimaera after affinity purification from
the saponin supernatant. Immunoblot
(C) and coomassie gel (D) of the
KAHRPWT chimaera after affinity purifi-
cation from the saponin supernatant.
The bands indicated by an arrow in (B)
and (D) were excised and subjected to
MS. The lowest band ( 26 kDa) is
degraded protein (YFP only). E) Mass
spectra of the most N-terminal peptide
from the band in (B) showing that
exported GBP130 was processed in
the PEXEL after leucine and acetylated
at the new N-terminus.
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pellet fractions, these included the five coat protein
complex II (COPII) proteins and three COPI subunits
(results not shown) and many exported proteins, suggest-
ing only partial solubilisation of our samples containing
vesicles enriched for proteins destined for export. The
supernatant fractions contained additional exported pro-
teins. We were able to identify the PEXEL-containing
peptide from seven endogenous proteins (Figure S1), six
of which were N acetylated (Table 1). Two of the proteins
have lysine in place of arginine in the PEXEL (Table 1),
indicating that lysine at position P3 can facilitate process-
ing within the PEXEL. Furthermore, two proteins con-
tained a predicted transmembrane spanning domain
(Table 1) suggesting that they traffic in a similar manner
as soluble proteins. Collectively, these data confirm that
PEXEL processing and N acetylation occur in a number of
endogenous exported proteins and validate our use of
chimeric proteins to study PEXEL function.
PEXEL processing and N acetylation occur before
export to the parasitophorous vacuole
As described above, we observed N-terminal processing
of chimaeras present in tetanolysin pellets (nonexported
proteins) (Figure 2A,C), indicating that processing occur-
red either within the parasite or in the parasitophorous
vacuole. We further analysed the location of N-terminal
processing and acetylation using saponin to fraction-
ate chimaeras present only in the parasite (pellet) from
those in the parasitophorous vacuole and erythrocyte
cytosol (supernatant). Transgenic P. falciparum-infected
erythrocytes were magnet purified, treated with 0.15%
saponin and analysed by immunoblot. We observed the
same profile of N-terminal processing of each chimaera in
both the pellet and the supernatant (Figure 4), indicating
that N-terminal processing occurred within the parasite.
We purified the GBP130WT YFP chimaera from the large-
scale saponin pellet sample, solubilised in Triton-X-100, by
immunoaffinity chromatography and subjected it to LC-
MS/MS. Similar to the saponin supernatant, we identified
the most N-terminal peptide at mass m/z 1178.49 with the
sequence Ac-
87AEGEDTCARK
96 (results not shown), indi-
cating that processing at PEXEL leucine and N acetylation
of GBP130 occurred before export to the parasitopho-
rous vacuole. We also observed significant amounts of
GBP130R>A, GBP130L>A and GBP130RILE>A chimaeras in
the saponin supernatant, indicating localisation in the
parasitophorous vacuole of the pools of mutant chimaeras
not processed in the PEXEL (Figure 4).
Attenuation of KAHRP PEXEL processing affects
signal sequence processing
We sought to characterise the N-termini of the different
protein populations presentwith respect to mutation ofthe
KAHRP PEXEL (Figure 2A). The KAHRPR>A chimeric pro-
teins were purified by immunoaffinity chromatography
from the saponin pellet (parasite located) and four GFP-
containing bands were observed (Figure 5A). The upper
two bands of 31 and 35 kDa were the same larger bands
observed previously (Figure 2A), while the lower two bands
represent some processing in the PEXEL of the large-scale
sample (29 kDa; also faintly present in Figure 2A) and
degradation to GFP (26.5 kDa; also present in Figure 2A),
respectively, The upper two bands were excised from a gel
(arrowsinFigure 5B)andsubjectedtoLC-MS/MS.Fromthe
31-kDa protein species (j in Figure 5B), we identified
the KAHRPR>A chimaera with 83% coverage and the most




indicating that this species was processed, not within
the PEXEL, but at the site predicted by SignalP (
32LKC-
SN
36) and, notably, was N acetylated.
Furthermore, for the 35-kDa species (r in Figure 5B), we
identified the KAHRPR>A chimaera with 75% coverage and




5D), indicating that this population of the KAHRPR>A
chimaera had retained the signal sequence. The presence
of these protein species indicates that attenuation of
processing within the KAHRP PEXEL because of a P3
arginine mutation results in processing at the signal
sequence or retention of the signal sequence. The detec-
tion of N acetylation following signal processing suggests
Table 1: Identification of endogenous Plasmodium falciparum proteins by MS that were processed within the PEXEL at leucine and
N acetylated






81 No 0 P T
PFD0115c RILVE
62VEFSNSYYYDEPK
74 Yes 0 S T
PFE0050w RVLAE
92AEQEDQYIR
100 Yes 0 S T
PFI1780w KSLAE
60AEASPEEHNNL
70 Yes 0 P C
PF10_0020 RKLAE
89AEALKDDERFEK
100 Yes 0 S T
PF13_0275 RILTQ
89TQGDHHEETEDVNHK
103 Yes 1 S T
MAL3P8.15 KSLAE
89AEMDHTK
95 Yes 1 S T
aNumber of putative transmembrane domains in the predicted protein.
bProteins coprecipitated from the saponin pellet (P) or supernatant (S).
cProteins were digested with trypsin (T) or chymotrypsin (C) for MS.
Traffic 2009; 10: 285–299 289
Role of the PEXEL in Plasmodium falciparum Protein Exportthat it may be common in processed proteins of
P. falciparum.
KAHRP and GBP130 chimaeras localise to the
ER in addition to the parasitophorous vacuole or
erythrocyte cytosol
To confirm the effect of PEXEL mutations on subcellular
localisation of the KAHRP and GBP130 chimaerae, we
used immunofluorescence analysis (IFA) to colocalise
them with known markers of the ER and parasitophorous
vacuole (Figures 6 and 7). Consistent with previous results
(19), we observed accumulation of each PEXEL mutant
chimaera in the parasitophorous vacuole, as shown by
colocalisation with the parasitophorous vacuole mem-
brane protein EXP-2 (Figures 6 and 7) (26). We also
observed colocalisation with the endoplasmic reticulum
calcium-binding protein ERC (Figures 6 and 7) (27) consist-
ent with the ER as a transit organelle during export. We
observed strong fluorescence of the KAHRPR>A,
KAHRPL>A and KAHRPRLQ>A GFP chimaeras in the ER
but decreased levels for the KAHRPQ>A GFP chimaera
(Figure 6). This may be attributed to accumulation at the
ER membrane of the subspecies of each mutant chimaera
that retained the signal peptide. If so, this would suggest
that the proteins were retained in a folded state.
We detected low-level fluorescence in the erythrocyte
cytosol of cells infected with P. falciparum expressing
KAHRPQ>A GFP and all GBP130 chimaeras; however, the
intensity varied between chimaeras and was always less
than that observed for the wild type chimaeras (Figures
6 and 7; refer also to Figure 2). Furthermore, we observed
a pattern of accumulation in the parasitophorous vacuole,
particularly for the KAHRPQ>A GFP chimaera, that appeared
inverse to the previously reported ‘necklace of beads’ (7),
suchthatsmallfocilacking anyfluorescence wereobserved
between larger fluorescent regions (Figure 6, panel Q>A,
see yellow arrows).
N acetylation does not require a native PEXEL
and is insufficient for correct export
To determine the requirement for N acetylation of the
cleaved PEXEL and protein export, we immunoaffinity
purified the GBP130E>A chimaera, as it was processed
identically to the GBP130WT chimaera (Figure 2C, lane 4),
but was poorly exported to the host cell (Figures 2D,H and
7). The chimaera was purified from both the saponin super-
natant and the pellet, verified by immunoblot (Figure 8A,C)
and excised from a gel (Figure 8B,D) and subjected to LC-
MS/MS. We identified the GBP130E>A chimaera from the
saponin supernatant with 46% coverage and the most
N-terminal peptide had a mass of m/z 992.39 with the
sequence Ac-
87AAGEDTCAR
95 (Figure 8E). We also identi-
fied the GBP130E>A chimaera from the saponin pellet with
41% coverage and the most N-terminal peptide had a mass
of m/z 992.39 with the sequence Ac-
87AAGEDTCAR
95
(Figure 8F). Collectively, this indicates that processing
within the PEXEL and N acetylation does not require the
PEXEL glutamic acid. Furthermore, substantial accumula-
tion of the GBP130E>A chimaera in the parasitophorous
vacuole indicates that processing within the PEXEL and N
acetylation is insufficient for normal export, underscoring
the important role played by the conserved PEXEL residue
after processing.
Discussion
Identification of the PEXEL/VTS (19,20) advanced our
understanding of P. falciparum-host interactions as it
Figure 4: Processing within the PEXEL occurs before export to the parasitophorous vacuole. Immunoblot with a-GFP antibodies
against GBP130 chimaeras fractionated with saponin indicates that processing occurred in the parasite fraction (pellet) before export.
Antibodies to aldolase were used to validate parasite membrane integrity following saponin treatment (note the presence of aldolase in the
pellet fractions but absence from the supernatant fractions) and reflects the quantity of protein loaded in each lane. More of the
GBP130R>A and GBP130L>A chimaera samples were loaded because of rapid loss of fluorescence over time in parasites overexpressing
these mutant chimaeras. The GBP130RILE>A chimaera traffics predominantly to the parasitophorous vacuole (see supernatant fraction).
That unprocessed bands of GBP130R>A, GBP130L>A and GBP130RILE>A are present in the supernatant fraction confirms breakdown of the
parasitophorous vacuole membrane by saponin.
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constitute the ‘exportome’ (22). While some studies have
characterised the function of exported proteins that con-
tain a PEXEL (14,21), little is known about the machinery
involved in their trafficking pathway or how each PEXEL
residue contributes to export. The PEXEL was recently
identified as a recognition sequence for protease process-
ing with subsequent N acetylation of the cleaved protein;
however, the function of the conserved amino acids in this
motif has not been addressed (24) nor has the function
Figure 5: Preventing KAHRP PEXEL
processing by mutation affects signal
sequence processing. Immunoblot (A)
and coomassie gel (B) of KAHRPR>A
chimeric proteins after immunoaffinity
purification from the saponin pellet. The
bands indicated by arrows in (B) were
excised and subjected to MS. C) Mass
spectra of the most N-terminal peptide
from the second upper band (j) in (B)
showing that the chimaera is processed
at the site predicted by SignalP (
32LKC-
SNN
36) and N acetylated. D) Mass spec-
tra of the most N-terminal peptide from
the uppermost band (r) in (B) showing
that the chimaera contains residues
present in the signal sequence (i.e. N-
terminal to the SignalP processing site;
31VLKC
34) and has retained the signal
sequence.
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we have determined the role of each conserved amino acid
within the PEXEL with respect to their requirement for
protease processing, N acetylation and export to the
infected erythrocyte.
Using subcellular fractionation, we have shown that
N-terminal processing of chimaeras occurs at the con-
served leucine in a PEXEL-dependent manner, within the
parasite, rather than the parasitophorous vacuole or during
translocation to the erythrocyte cytosol. Identification of
PEXEL cleavage at the conserved leucine is in agreement
with a recent study (24). Their work also showed that
brefeldin A (BFA), which inhibits PfSec7 in ER-to-Golgi
transport (28), does not disrupt PEXEL processing and
concluded that this event occurs early in the trafficking
pathway within the ER. However, it is possible that
treatment with BFA prevented the anterograde transport
of the PEXEL protease in those experiments. Using
different methodology, we come to a similar conclusion
that suggests PEXEL processing occurs within the ER.
Therefore, the fate of proteins destined for export is
decided early, as previously hypothesised (29) and involves
proteolytic cleavage in a manner dependent on the PEXEL
arginine and leucine residues.
It was also shown that N acetylation occurs following
PEXEL processing, and it was suggested that this could
provide a mechanism to distinguish proteins that are
destined to be exported (24). A model was proposed
where the cleaved PEXEL (xE/Q/D) was required for
N acetylation (24). Our analysis shows that after cleavage,
either at the PEXEL motif or of the signal peptide,
N acetylation occurs suggesting that it is common in
P. falciparum. Analysis of the GBP130E>A chimaera
showed that the PEXEL was still cleaved after leucine
and N acetylated; however, it was not exported but was
trafficked by the default pathway to the parasitophorous
vacuole, as shown previously for other GFP reporters that
lack a PEXEL (30). This demonstrates that the PEXEL
glutamic acid is not required for cleavage at the P1 leucine
and that it is dispensable for N acetylation. Furthermore,
accumulation of the GBP130E>A chimaera in the para-
sitophorous vacuole indicates that although PEXEL pro-
cessing and N acetylation of exported proteins occur both
events are insufficient for normal export. This shows that
xE/Q/D remaining after PEXEL cleavage plays an import-
ant role in export. We also identified an endogenous
P. falciparum protein that was cleaved in the PEXEL at
leucine but was not N acetylated. This protein was
recovered from the saponin pellet, and thus, we cannot
confirm that it was exported; however, this does represent
the first example of a protein containing a native PEXEL
that was cleaved at the P1 leucine but not N acetylated.
The consequence of PEXEL mutations in reporter proteins
has been determined by microscopy to show that the
conserved residues are required for efficient export to the
Figure 6: KAHRP chimaeras localise to the endoplasmic reticulum in addition to the parasitophorous vacuole or erythrocyte
cytosol. Images captured by immunofluorescence microscopy show substantial colocalisation of KAHRP chimaeras with the endoplasmic
reticulum protein ERC (left panels). Intraparasitic fluorescence is also evident when chimaeras were colocalised with the parasitophorous
vacuole membrane protein EXP-2 (right panels). Only the wild type (WT) PEXEL chimaera (uppermost panels) is efficiently exported to the
erythrocyte cytosol, but low-level fluorescence in the erythrocyte cytosol was observed for the KAHRPQ>A chimaera. All mutants show
some accumulation within the parasitophorous vacuole but while the KAHRPQ>A chimaera colocalises with ERC less than the other
KAHRPmutants(leftpanel),it accumulatesmoreintheparasitophorousvacuoleinslightlyolderparasites(rightpanel).Accumulationof the
KAHRPQ>A chimaera in the parasitophorous vacuole appeared inverse to the ‘necklace of beads’ observation described previously (7; see
yellow arrows in right panel). The white bar in the last panel corresponds to 2 mm for each of the panels within the figure.
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Boddey et al.infected erythrocyte (19,20,31). We have extended this
analysis by determining the effect of mutations on cleav-
age of the PEXEL as well as export. Mutation of leucine
within the PEXEL interferes with processing and conse-
quently blocks export to the erythrocyte. Moreover, chi-
maeras containing a mutation of arginine in the PEXEL had
a similar processing profile to the leucine mutants; thus,
processing at the P1 leucine is also dependent on arginine
at position P3. This is consistent with the strong conser-
vation of these two residues in all the exported proteins
that have been defined (19,20,22). It is noteworthy that we
also identified two endogenous proteins that were pro-
cessed at the PEXEL leucine that contained lysine in place
of arginine at position P3. This indicates that lysine is
suitable for processing of those proteins and validates the
presence of KxLxE/Q/D proteins in the predicted expor-
tome (22). It is interesting that the leucine to alanine
mutation in both GBP130 and KAHRP still allowed some
cleavage, albeit inefficient, and as a consequence, some
export was observed. This is perhaps not surprising given
the similarity in structure of alanine compared with leucine,
as both are nonpolar, aliphatic, hydrophobic molecules
often buried in folded proteins. Significantly, when all three
conserved PEXEL residues were mutated, cleavage, and
consequently, export, was inhibited entirely.
A substantial proportion of the chimeric protein pools were
present in the ER, as shown by colocalisation with ERC.
We believe that GFP derived from cleaved chimaeras
should account for little of this colocalisation, as degrada-
tion of reporter proteins to GFP alone is thought to occur in
the food vacuole (30). It is likely that this fluorescence
represents transit through the ER of the chimeric proteins
that are exported, or which traffic to the parasitophorous
vacuole, and examples of this include the KAHRPwt,
KAHRPQ>A and GBP130E>A chimaeras and a truncated
STEVOR-GFP chimaera described recently (32). In con-
trast, the KAHRPR>A, KAHRPL>A and KAHRPRLQ>A pools
that have an intact signal sequence appear to have been
retained in the ER membrane, explaining the high level of
fluorescence observed there. It was surprising to identify
by MS a subpopulation of the KAHRPR>A chimaera that
had retained the signal sequence, and we infer that similar
subpopulations of the KAHRPL>A and KAHRPRLQ>A also
retained the signal sequence, the latter of which is of
particular interest as there is no PEXEL remaining. One
possibility to explain this is that the signal peptidase
complex is involved in cleaving the PEXEL, as has been
recently suggested (24). It is also possible that the PEXEL
protease resides in close proximity to the signal peptidase,
or even segregates/cleaves this motif beforehand, and that
a combination of overexpression and inhibition of PEXEL
processing because of mutation is associated with signal
peptide retention. Interestingly, we did not specifically
observe GBP130 with a signal sequence retained, and
a significant proportion of mutant GBP130 chimaeras
(particularly RILE>A) were observed in the saponin super-
natant, suggesting localisation in the parasitophorous
Figure 7: GBP130 chimaeras localise to the endoplasmic reticulum in addition to the parasitophorous vacuole or erythrocyte
cytosol. Images captured by immunofluorescence microscopy show substantial colocalisation of GBP130 chimaeras with the endo-
plasmic reticulum protein ERC (left panels). Intraparasitic fluorescence is also evident when chimaeras were colocalised with the
parasitophorous vacuole membrane protein EXP-2 (right panels). Only the wild-type PEXEL chimaera is efficiently exported to the
erythrocyte cytosol (uppermost panels). All mutants show some accumulation within the parasitophorous vacuole and low-level
fluorescence in the erythrocyte cytosol (lower panels), and this is evident, upon careful examination, in previously published images of
these chimaeras (19). The presence of GBP130RILE>A in the saponin supernatant in Figure 4 suggests localisation predominantly in the
parasitophorous vacuole (signal sequence processed). This is confirmed by immunofluorescence microscopy (compare GBP130RILE>A in
this figure to KAHRPRLQ>A in Figure 6, the latter of which retains the signal sequence and localises more in the ER as a result). The white
bar in the last panel corresponds to 2 mm for each of the panels within the figure.
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less GBP130RILE>A in the ER compared with KAHRPRLQ>A
and this is likely to be because of the retention of the signal
sequence for the latter chimaera. These differences
between GBP130 and KAHRP chimaeras may be because
of a number of factors, including different temporal
expression (Figure 1), possible differences in episomal
expression (Figure 2), the length of the atypical signal
Figure 8: PEXEL processing and N
acetylation does not require the full-
length PEXEL. Immunoblot (A) and
coomassie gel (B) of the GBP130E>A
chimaera after affinity purification from
the saponin pellet. Immunoblot (C) and
coomassie gel (D) of the GBP130E>A
chimaera after affinity purification from
the saponin supernatant. The bands
indicated by an arrow in (B) and (D)
wereexcisedandsubjectedtoMS.The
lowest band ( 26 kDa) is degraded
protein (YFP only). E) Mass spectra of
the most N-terminal peptide from the
band in (B) showing that GBP130E>A
was processed in the parasite (pellet)
within the PEXEL after leucine and N
acetylated. F) Mass spectra of the
most N-terminal peptide from the band
in (D) showing that GBP130E>A in the
parasitophorous vacuole (supernatant)
was processed in the PEXEL after
leucine and N acetylated.
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that of KAHRP, or the distance between the predicted
SignalP processing site and the PEXEL, which is 5 residues
shorter for GBP130 than KAHRP. Although the exact
nature of the PEXEL protease is unknown all the current
data support the notion that cleavage occurs in the parasite
ER (24). We consider it unlikely that our PEXEL chimaeras
docked at the external leaflet of the ER membrane (29), as
this would require processing of the PEXEL, which is BFA
insensitive (24), on the cytoplasmic side of the ER mem-
brane and this would release soluble proteins into the
cytoplasm. Furthermore, we detected processing of the
signal sequence of KAHRP and GBP130 when PEXEL
processing was inhibited, indicating that these mutant
chimaeras had access to the ER lumen.
Blockage of PEXEL processing in the KAHRP chimaera
allowed determination of the signal peptidase cleavage
site, which was identical to that predicted by SignalP (33).
This is the first confirmation of the signal sequence
processing site in KAHRP, and of any P. falciparum protein,
and indicates that signal peptidase specificity is conserved
with other eukaryotes. Additionally, processed KAHRP
was acetylated at the new N-terminus following signal
sequence cleavage, a feature that was also found in other
N-terminal peptides in our proteomic analysis. The role of
N acetylation following signal sequence processing in
P. falciparum is unknown; however, as the KAHRPR>A
chimaera did not export correctly, it by itself is insufficient
for export to the erythrocyte.
We have used soluble exported proteins as models in this
study. There are a class of exported proteins that have
a signal sequence, PEXEL and up to two putative trans-
membrane regions that would be inserted into a membrane
in the parasite-infected erythrocyte (31). In the proteomic
analysis, we have identified proteins with putative trans-
membrane spanning regions that are cleaved after leucine
withinthePEXEL.Itislikelythattheyaretraffickedinasimilar
manner as soluble proteins, either as soluble complexes or
through the ER membrane to the vesicular machinery.
While cleavage of the PEXEL motif at leucine, revealing xE/
Q/Dat the resulting N-terminus, isa requirement forexport
to the erythrocyte, the route and machinery involved are
unknown. Endomembrane protein transport involves traf-
ficking through protein-coated vesicles to target mem-
branes. Polymerisation of COPII proteins at the transi
tional ER generates vesicles for transport from the ER
and the heptameric COPI complex, along with ARF1, gene-
rates vesicles for reterograde transport (reviewed in 34).
To achieve sorting, transmembrane cargo can interact
directly with coat proteins; however, soluble cargo re-
quires transmembrane receptors (reviewed in 35). Alter-
natively, proteins may traffic indirectly by bulk flow (36).
Plasmodium falciparum contains all the COPII subunits
(37–41) and at least four COPI subunits (alpha, beta, delta
and epsilon) (42,43); however, the exact nature of vesicles
that fuse with the parasite membrane is unknown. There
are two likely pathways for export of proteins from the ER
to the parasite-infected erythrocyte (Figure 9). In the first
model, proteins to be exported are cotranslationally
inserted into the ER membrane using the signal sequence,
allowing cleavage by signal peptidase and/or recognition of
the PEXEL by a specific protease that cleaves this motif.
This reveals xE/Q/D at the N-terminus of the protein, which
is trafficked to the Golgi and parasitophorous vacuole
through the general secretory pathway using the COPII
machinery. Once released into the parasitophorous vacu-
ole a translocon, that has been hypothesised previously
(2,19,31,44), would recognise the cleaved motif for export
to the erythrocyte. While this model is possible, it would
seem less likely as some proteins that are not exported,
but may be secreted into the parasitophorous vacuole,
would have xE/Q/D revealed after cleavage of the signal
sequence (Boddey and Cowman, unpublished), and these
mature proteins would be indistinguishable from those
destined for export.
In the second model, proteins with xE/Q/D at the N-
terminus after PEXEL cleavage in the ER may be sorted
by a specific transmembrane PEXELcargo receptor (soluble
PEXEL proteins) or through interaction of the cytoplasmic
domain (PEXEL proteins with transmembrane domain) into
vesicles by the COPII machinery (Figure 9). Because an
exported chimaera was recently shown to traffic through
the Golgi(32),it isalsopossiblethat sorting occurstherebut
this again would rely on a minimal sorting sequence after
PEXEL cleavage (xE/Q/D). It is unknown if N acetylation
combined with xE/Q/D provides the sorting information.
Vesicles with cargo to be exported rather than secreted
would be functionally differentiated (29) by vesicle soluble
N-ethylmaleimide-sensitive fusion protein attachment pro-
tein receptors (v-SNAREs) and would bind to the cognate
target SNARE at specific domains at the parasite mem-
brane, releasing the cargo into the parasitophorous vacuole.
It has previously been reported that PEXEL-containing
chimaeras within the parasitophorous vacuole have the
appearance of a necklace of beads that are resistant to
recovery after photobleaching, suggesting the presence of
subcompartments within this space (7,45). These compart-
ments may house a translocon that identifies and trans-
locates proteins trafficked there. Thus, nonexported
proteins would traffic through the default secretory path-
way, which may involve bulk flow, to compartments in the
parasitophorous vacuole that lack the translocon.
There are clearly many gaps in our understanding of the
intricacies of the export pathway in P. falciparum. How-
ever, this work describes the initial molecular events
required for effector protein export and, in defining the
role of the PEXEL, significantly enhances our understand-
ing of the export cascade in P. falciparum-infected cells.
With malarial resistance to current therapies increasing
worldwide, this export pathway represents an excellent,
novel target for the design of new antimalarial drugs.
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Role of the PEXEL in Plasmodium falciparum Protein ExportFigure 9: Role of the PEXEL in export of Plasmodium falciparum proteins to the infected erythrocyte. Two proposed models of
PEXEL-mediated export are shown (A, 1 and 2). A1) After cotranslational insertion through Sec61 at the rough endoplasmic reticulum (rER)
using the signal sequence, proteins to be exported are either processed by signal peptidase (red pac-man) or sequestered and/or
processed by the PEXEL protease (yellow pac-man) and sorted at the transitional endoplasmic reticulum (tER) for transport through the
Golgi to the parasitophorous vacuole by the default secretory pathway. There, proteins to be exported (xE/Q/D after PEXEL processing;
green protein), are recognised and trafficked across the parasitophorous vacuole membrane by a translocon. Secreted or mutated PEXEL
proteins are depicted as red proteins. A2) After entry at the rER and sequestration and/or processing by either signal peptidase (red pac-
man) or the PEXELprotease(yellow pac-man),proteinsto be exportedare differentially sorted eitherat the tER or at the Golgi into vesicles.
This may occur through a specific transmembrane PEXEL cargo receptor that enriches functionally distinct vesicles for exported proteins
(greenproteins),whicharetargetedtosubcompartments(the‘necklaceofbeads’;depictedas whitecompartmentsin theparasitophorous
vacuole) of the parasitophorous vacuole that houses the translocon. Exported transmembrane proteins then presumably diffuse laterally
from the translocon and traffic with forming Maurer’sclefts (white structuresin the erythrocyte). Secreted proteins (red)traffic through the
default secretory pathway to alternative compartments of the parasitophorous vacuole that do not contain the translocon. The default
pathway may involve bulk flow, depicted as free red proteins in the ER that ‘sample’ the budding membrane. Uncharacterised vesicles are
depicted by ‘?’. Close up (box) of the possible sorting mechanism is shown in (B) and (C). B) After cotranslational insertion into the rER
PEXEL proteins are sequestered/processed by the PEXEL protease and sorted into vesicles through a transmembrane cargo receptor that
interacts with the COPII machinery. C) Secreted proteins are not recognised by the PEXEL receptor but bind either a different receptor or
traffic through bulk flow. The role of the Golgi is unclear but similar sorting may occur there.
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Parasites, plasmid constructs and transfection
Plasmodium falciparum strain 3D7 and transgenic parasites were cultured
in human Oþ erythrocytes at 4% haematocrit in RPMI 1640 medium
supplemented with 25 mM HEPES pH 7.4, 0.2% sodium bicarbonate and
0.5% Albumax II (Invitrogen) in an atmosphere consisting of 5% CO2,5 %
O2 and 90% N at 378C. For consistency, we used the C-terminal GFP- and
YFP-tagged chimaeras reported previously (19) to study the modifications
at the N-termini of the PEXEL chimaeras when expressed in P. falciparum.
Transgenic parasites expressing KAHRPR>A-, KAHRPL>A-a n dK A H R P RLQ>A-
GFP chimaeras were generated previously (19) and thawed from liquid
nitrogen. Transgenic parasites expressing KAHRPWT-, GBP130WT-,
GBP130R>A-, GBP130L>A-, GBP130E>A- and GBP130RILE>A-YFP chimaeras
were generated by transfection of plasmids constructed previously (19).
Transgenic parasites expressing the KAHRPQ>A-GFP chimaera contained the
construct pJABKQ>AGlux.1, which was made by amplifying the N-terminal
sequence of KAHRP (PFB0100c) from 3D7 genomic DNA using the
oligonucleotides JB102, 50-gatctcgagATGAAAAGTTTTAAGAACAAAAA-
TACTTTGAGG-30 andJB103,50-gatcccgggATGGTGATGGTGGTGATGGTGTT-
CATGTTGCTTTGCTGC-30, which introduced a Q58 to A point mutation. The
amplicon was cloned into pGlux.1 using Xho Ia n dXma I( u n d e r l i n e d )
generating pJABKQ>AGlux.1. All plasmids (100 mg) were transfected into
3D7 as previously described (46) and selected with 5 nM WR99210.
Trophozoite-infected erythrocytes grown to 5–10% parasitaemia were puri-
fied from uninfected cells by magnet separation through CS columns and
Vario Macs magnet (Miltenyi Biotech).
Sample fixation and immunofluorescence microscopy
Erythrocytes infected with transgenic parasites were fixed in 4% para-
formaldehyde, 0.01% glutaraldehyde (Electron Microscopy Sciences) for
30 min to maintain GFP fluorescence and permeabilised in 0.1% Triton-X-
100 in PBS for 10 min, all at room temperature. Cells were incubated with
rabbit a-Pf ERC (1:500) or mouse a-Pf EXP-2 (1:500) for 2 h followed by
Alexa Fluor 594-conjugated secondary immunoglobulin G antibodies
(1:1000; Molecular Probes) for 1 h and nuclei were labelled with 4’-6-
Diamidino-2-phenylindole (DAPI) nuclear stain (Roche) at 0.2 mg/mL in
Vectorshield (Vector Labs). Cells were viewed with a Carl Zeiss Axioskop
2 microscope (Thornwood) and images collected using a PCO SensiCam
(Motion Engineering Co.) and AXIOVISION 3 software (Carl Zeiss). Images
were assembled with Photoshop CS2 v9.0.2 (Adobe).
Subcellular fractionation, SDS–PAGE, immunoblot
and densitometry
For tetanolysin fractionation, 2   10
8 infected erythrocytes were gently
mixed in a solution containing 100 U/mL tetanolysin (Sigma), 0.2% bovine
serum albumin (BSA; Sigma), 1  complete protease inhibitor cocktail
(Roche) in PBS and incubated for 20 min at 378C. Cells were separated
into supernatant and pellet and the pellet was washed with PBS. For
saponin fractionation, 2   10
8 infected erythrocytes were gently mixed in
a solution containing 0.09% saponin (Sigma) 0.2% BSA, 1  complete
protease inhibitor cocktail in PBS for 10 min on ice. Cells were separated
into supernatant and pellet and pellets were washed with PBS. All fractions
were stored at  208C. Samples were resuspended in 4  reducing SDS–
PAGE sample buffer, boiled and subjected to SDS–PAGE in 10% Bis/Tris
precast polyacrylamide gels (Invitrogen) and transferred to nitrocellulose
membrane using an iBlot (Invitrogen). Membranes were blocked for 1 h in
5% skim milk (Diploma) in PBS containing 0.1% Tween-20 (Sigma).
Membranes were probed with mouse a-GFP antibody (Roche; 1:1000) or
rabbit a-Pf aldolase (1:1000) followed by horseradish peroxidase-conju-
gated secondary antibodies (Silenius; 1:2000) and visualised using
enhanced chemiluminescence (Amersham). Densitometry of varying ex-
posures within the linear range of blots scanned at 400 dpi was undertaken
using QUANTITY ONE V4.6.3 software (Bio-Rad). Comparisons were made
only between equivalent loadings of pellet and supernatant fractions of
each chimaera, not between different chimaeras. Band intensities were
converted to proportions of whole tagged protein to account for potential
errors arising from the Schwarzchild effect and to allow direct comparisons
between different chimaeras.
Chimaera preparation and purification by
immunoaffinity chromotography
Following synchronisation with 1% sorbitol treatment, 1 L of transgenic
parasites (per chimaera) were grown at 4% haematocrit in the presence of
20–40 nM WR99210 selection to >10% parasitaemia of trophozoites and
purified by large-scale magnet separation through D columns and Super
Macs magenet (Miltenyi biotech). Infected cells were fractionated with
0.15% saponin containing 1  complete protease inhibitor cocktail in PBS
for 10 min on ice, separated into supernatant and pellet, and pellets were
washed with PBS and all fractions were snap frozen on dry ice and stored at
 808C. Tagged chimaeras were purified directly form the saponin super-
natant by mixing with 200 mLo fa-GFP agarose (MBL) at 48Cf o r2h .
Tagged chimaeras were solubilised from the saponin pellet in 10 pellet
volumes of 1% Triton-X-100 in PBS containing 1  complete protease
inhibitor cocktail and purified with a-GFP agarose, as above. Beads were
thoroughly washed with PBS and eluted in 300 mL 150 mM Tris pH6.8,
2m M ethylenediaminetetraacetic acid, 0.5% SDS for 10 min at room
temperature, trichloroacetic acid precipitated, resuspended in SDS–PAGE
sample buffer, separated by SDS–PAGE and either immunoblotted with
a-GFP antibodies or stained in Imperial Protein stain (Pearce).
Gel excision and digestion
For each sample, gel bands ( 2 mm) were excised from the 1-D gel lane
and subjected to automated in-gel reduction, alkylation and tryptic digestion
using the MassPREP Station (Micromass). Briefly, gel sections were
automatically reduced with 10 mM DTT (Merck) for 30 min, alkylated for
20 min with 25 mM iodoacetic acid (Fluka) and digested with 150 ng trypsin
(Worthington) or chymotrypsin (Roche Biochemicals) for 4.5 h at 378C.
Extracted peptide solutions (0.1% formic acid) were concentrated to
approximately 10 mL by centrifugal lyophilisation using a SpeedVac AES
1010 (Savant) for nano-LC in conjunction with collisional tandem mass
spectrometry (nano-LC-MS/MS).
Nano-LC-MS/MS
A 96-well plate containing extracted peptides was placed into the micro
autosampler for injection and fractionation by nanoflow reverse-phase LC on
a nano-LC system (1200 series, Agilent) using a nanoAcquity C18
150   0.15 mm ID column (Waters) developed with a linear 60-min gradient
withaflowrateof0.5 mL/minat458Cfrom100%solventA(0.1%formicacid
in Milli-Q water) to 100% solvent B [0.1% formic acid, 60% acetonitrile
(Mallinckrodt) 40% Milli-Q water]. The nano-high-performance LC was
coupled on-line to an LTQ-Orbitrap mass spectrometer equipped with
a nanoelectrospray ion source (Thermo Fisher Scientific) for automated MS/
MS. The LTQ-Orbitrap was operated in positive ion mode for data-dependent
acquisition.SurveyMS scans were acquiredwith theresolutionset to a value
of 30 000. Each scan was recalibrated in real time by co-injecting of
protonated polydimethylcyclosiloxane as an internal standard from ambient
air into the C-trap. Up to five most intense ions per cycle were fragmented
and analysed in the linear trap, with target ions already selected for MS/MS
being dynamically excluded for 3 min.
Mass spectra database searching, protein
identification and bioinformatic analysis
Mass spectra peak lists were extracted using extract-msn as part of
Bioworks 3.3.1 (Thermo Fisher Scientific) linked into Mascot Daemon
(Matrix Science). The parameters used to generate the peak lists for the
Orbitrap were as follows: minimum mass 400, maximum mass 5000,
grouping tolerance 0.01 Da, intermediate scans 1, minimum group count 1
and 10 peaks minimum and total ion current of 100. Peak lists for each
nano-LC-MS/MS run were used to search MASCOT v2.2.04 search
algorithm (Matrix Science) provided by the Australian Proteomics Compu-
tational Facility (www.apcf.edu.au). Automatic charge state recognition
was used because of the high-resolution survey scan (30 000). LC-MS/MS
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database containing the PEXEL constructs and also including a small
contaminant database (keratins, trypsin, chymotrypsin, etc.). The search
parameters consisted of carboxymethylation of cysteine as a fixed modi-
fication (þ58 Da) with variable modifications set for NH2-terminal acetyla-
tion (þ42 Da) and oxidation of methionine (þ16 Da). A peptide mass
tolerance of  20 p.p.m., #13C defined as 1, fragment ion mass tolerance
of  0.8 Da and an allowance for up to three missed tryptic cleavages for
Orbitrap data.
The signal sequence processing site of KAHRP was predicted by SignalP
3.0 (http://www.cbs.dtu.dk/services/SignalP/) with both neural networks
and hidden Markov models trained on eukaryotes (33). The signal sequence
processing site of GBP130 was predicted as above with SignalP 1.1 (http://
www.cbs.dtu.dk/services/SignalP-1.1/) (47).
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Supplementary Information
Additional Supporting Information may be found in the online version of
this article:
Figure S1: Mass spectra from seven endogenous Plasmodium
falciparum proteins processed in the PEXEL. Endogenous proteins that
coprecipitated with the tagged PEXEL chimaeras were identified by MS.
The most N-terminal peptide from seven endogenous proteins that were
processed at the PEXEL leucine were identified and six such peptides were
N acetylated. The mass spectra for each peptide are shown and correspond
to the following proteins: A) PFA0210c, B) PFD0115c, C) PFE0050w, D)
PFI1780w, E) PF10_0020, F) PF13_0275 and G) MAL3P8.15.
Figure S2: Tagged chimaeras are degraded back to GFP. Immunoblot
(A) and coomassie gel (B) of KAHRPR>A chimeric proteins after immunoaf-
finity purification from the saponin pellet. The band indicated by an arrow in
(B) was excised and subjected to MS. C and D) Mass spectra of the two
most N-terminal peptides identified from the smallest band (s) in (B) shows





Seventy-two per cent sequence coverage of the full-length chimaera (94%
of the GFP sequence) was obtained.
Please note: Wiley-Blackwell are not responsible for the content or
functionality of any supporting materials supplied by the authors. Any
queries (other than missing material) should be directed to the correspond-
ing author for the article.
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